Incyte Corp (NASDAQ:INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar pchop123 (76.64) Submitted: 7/10/2012 10:16:55 AM : Underperform Start Price: $25.89 INCY Score: +5.50

Take some recent gains in this one now as it is running out of gas

Report this Post Reply

Featured Broker Partners


Advertisement